Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00975845 · ClinicalTrials.gov registry record
BioCleanse Tibialis Tendon Anterior Cruciate Ligament (ACL) Study
A clinical trial, sponsored by RTI Surgical.
- Completed
- Registry status
- 40
- Enrollment target
NCT00975845: Completed study, sponsored by RTI Surgical.
NCT00975845 is a clinical trial that has completed, run by RTI Surgical. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00975845 has completed, sponsored by RTI Surgical.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
To compare the outcome of Anterior Cruciate Ligament (ACL) reconstruction performed using the tibialis allograft to historical outcomes of ACL reconstruction patients and to establish if any correlation exists between the age of the graft donor and the clinical outcomes.
Primary Outcome
The International Knee Documentation Committee (IKDC) is a knee-specific patient-reported outcome measure. This is an indexed score form 0-100, with 0 being the worst possible status and 100 indicating no dysfunction, disability or pain.
Interventions
- OTHER BioCleanse Tibialis tendon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2017-11-09 |
| Est. Completion | 2017-11-09 |
What the finished NCT00975845 record still lists
NCT00975845 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which BioCleanse Tibialis tendon is the first listed.
NCT00975845 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00975845 about?
NCT00975845 is a clinical study titled "BioCleanse Tibialis Tendon Anterior Cruciate Ligament (ACL) Study". To compare the outcome of Anterior Cruciate Ligament (ACL) reconstruction performed using the tibialis allograft to historical outcomes of ACL reconstruction patients and to establish if any correlation exists between the age of the graft donor and the clinical outcomes.
What is the current status of trial NCT00975845?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2017-11-09. Estimated completion is 2017-11-09.
What interventions are being tested in trial NCT00975845?
The interventions under investigation include: BioCleanse Tibialis tendon (OTHER).
Who is sponsoring clinical trial NCT00975845?
This trial is sponsored by RTI Surgical, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI